Banendu Sunder Dash

736 total citations
24 papers, 528 citations indexed

About

Banendu Sunder Dash is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Banendu Sunder Dash has authored 24 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 14 papers in Biomaterials and 5 papers in Materials Chemistry. Recurrent topics in Banendu Sunder Dash's work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (11 papers) and Graphene and Nanomaterials Applications (11 papers). Banendu Sunder Dash is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (11 papers) and Graphene and Nanomaterials Applications (11 papers). Banendu Sunder Dash collaborates with scholars based in Taiwan, India and Germany. Banendu Sunder Dash's co-authors include Jyh‐Ping Chen, Yu‐Jen Lu, Gils Jose, Yu‐Jen Lu, Huai‐An Chen, Chih‐Hao Chen, Chi‐Cheng Chuang, Yin‐Kai Chao, Rama Shanker Sahu and Hung‐Wei Yang and has published in prestigious journals such as ACS Applied Materials & Interfaces, International Journal of Molecular Sciences and International Journal of Pharmaceutics.

In The Last Decade

Banendu Sunder Dash

22 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Banendu Sunder Dash Taiwan 13 374 220 177 80 54 24 528
Guangxi Zhai China 10 437 1.2× 271 1.2× 227 1.3× 101 1.3× 39 0.7× 10 592
Haina Tian China 13 402 1.1× 218 1.0× 200 1.1× 108 1.4× 56 1.0× 27 528
Linxia Zhang China 7 239 0.6× 300 1.4× 212 1.2× 141 1.8× 37 0.7× 16 642
Dongbo Guo China 12 285 0.8× 167 0.8× 176 1.0× 171 2.1× 67 1.2× 27 582
Menghong Xu China 12 485 1.3× 149 0.7× 160 0.9× 133 1.7× 40 0.7× 19 612
Seulgi Han South Korea 12 406 1.1× 153 0.7× 350 2.0× 133 1.7× 64 1.2× 23 828
Nerea Iturrioz-Rodríguez Spain 13 273 0.7× 203 0.9× 130 0.7× 137 1.7× 28 0.5× 19 491
Jiayue Zhao China 8 545 1.5× 246 1.1× 279 1.6× 123 1.5× 56 1.0× 11 728
Wenxian Du China 13 585 1.6× 290 1.3× 431 2.4× 168 2.1× 64 1.2× 25 826
Xinlian Zhao China 7 288 0.8× 248 1.1× 138 0.8× 123 1.5× 33 0.6× 8 551

Countries citing papers authored by Banendu Sunder Dash

Since Specialization
Citations

This map shows the geographic impact of Banendu Sunder Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banendu Sunder Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banendu Sunder Dash more than expected).

Fields of papers citing papers by Banendu Sunder Dash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Banendu Sunder Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banendu Sunder Dash. The network helps show where Banendu Sunder Dash may publish in the future.

Co-authorship network of co-authors of Banendu Sunder Dash

This figure shows the co-authorship network connecting the top 25 collaborators of Banendu Sunder Dash. A scholar is included among the top collaborators of Banendu Sunder Dash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Banendu Sunder Dash. Banendu Sunder Dash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dash, Banendu Sunder, et al.. (2025). Electrospun Aligned Gelatin/Chitosan Nanofibrous Membranes for a Better Culture of Mesothelial Cells. Journal of Composites Science. 9(1). 31–31. 2 indexed citations
3.
Dash, Banendu Sunder, et al.. (2025). Folic Acid-Conjugated Magnetic Oleoyl-Chitosan Nanoparticles for Controlled Release of Doxorubicin in Cancer Therapy. Nanomaterials. 15(6). 415–415. 7 indexed citations
6.
7.
Dash, Banendu Sunder, et al.. (2024). Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma. International Journal of Biological Macromolecules. 260(Pt 1). 129401–129401. 21 indexed citations
8.
Dash, Banendu Sunder, et al.. (2024). Magnetic lipid-poly(lactic-co-glycolic acid) nanoparticles conjugated with epidermal growth factor receptor antibody for dual-targeted delivery of CPT-11. International Journal of Pharmaceutics. 667(Pt A). 124856–124856. 4 indexed citations
9.
10.
Chen, Chih‐Hao, et al.. (2024). Bone Tissue Engineering with Adipose-Derived Stem Cells in Polycaprolactone/Graphene Oxide/Dexamethasone 3D-Printed Scaffolds. ACS Biomaterials Science & Engineering. 10(10). 6425–6440. 2 indexed citations
11.
Dash, Banendu Sunder, Oleg Prymak, Κateryna Loza, et al.. (2024). Doxorubicin-Loaded Ultrasmall Gold Nanoparticles (1.5 nm) for Brain Tumor Therapy and Assessment of Their Biodistribution. ACS Applied Bio Materials. 7(10). 6890–6907. 7 indexed citations
12.
Chen, Huai‐An, Yu‐Jen Lu, Banendu Sunder Dash, Yin‐Kai Chao, & Jyh‐Ping Chen. (2023). Hyaluronic Acid-Modified Cisplatin-Encapsulated Poly(Lactic-co-Glycolic Acid) Magnetic Nanoparticles for Dual-Targeted NIR-Responsive Chemo-Photothermal Combination Cancer Therapy. Pharmaceutics. 15(1). 290–290. 28 indexed citations
13.
Dash, Banendu Sunder, et al.. (2023). Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications. International Journal of Molecular Sciences. 24(13). 10546–10546. 8 indexed citations
14.
Dash, Banendu Sunder, et al.. (2023). Cetuximab-Conjugated Magnetic Poly(Lactic-co-Glycolic Acid) Nanoparticles for Dual-Targeted Delivery of Irinotecan in Glioma Treatment. Materials. 16(16). 5526–5526. 5 indexed citations
15.
Dash, Banendu Sunder, et al.. (2022). Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy. Biomaterials Advances. 136. 212764–212764. 50 indexed citations
16.
Chen, Chih‐Hao, et al.. (2022). PLGA/Gelatin/Hyaluronic Acid Fibrous Membrane Scaffold for Therapeutic Delivery of Adipose-Derived Stem Cells to Promote Wound Healing. Biomedicines. 10(11). 2902–2902. 23 indexed citations
17.
Chen, Chih‐Hao, et al.. (2021). Tension Stimulation of Tenocytes in Aligned Hyaluronic Acid/Platelet-Rich Plasma-Polycaprolactone Core-Sheath Nanofiber Membrane Scaffold for Tendon Tissue Engineering. International Journal of Molecular Sciences. 22(20). 11215–11215. 35 indexed citations
18.
Dash, Banendu Sunder, Yu‐Jen Lu, Huai‐An Chen, Chi‐Cheng Chuang, & Jyh‐Ping Chen. (2021). Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy. Materials Science and Engineering C. 128. 112311–112311. 41 indexed citations
20.
Dash, Banendu Sunder, Gils Jose, Yu‐Jen Lu, & Jyh‐Ping Chen. (2021). Functionalized Reduced Graphene Oxide as a Versatile Tool for Cancer Therapy. International Journal of Molecular Sciences. 22(6). 2989–2989. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026